Genetic and metabolic description of five patients with Berardinelli-Seip syndrome;Síndrome de berardinelli-seip:Descrição genética e metabólica de cinco pacientes

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 1, 2011, Pages 54-59

  Barra, Cristiane B ^a   Savoldelli, Roberta D ^a   Manna, Thais D ^a   Kim, Chong A ^a   Magre, Jocelyn ^b   Porta, Gilda ^a   Setian, Nuvarte ^a   Damiani, Durval ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSERM   (France)

Author keywords

Congenital generalized lipodystrophy; Hypercholesterolemia; Hypertriglyceridemia; Insulin resistance; diabetes mellitus; Leptin

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; CAV1 PROTEIN, HUMAN; CAVEOLIN 1; LEPTIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; CONGENITAL GENERALIZED LIPODYSTROPHY; DIABETES MELLITUS; FEMALE; GENETICS; HUMAN; HYPERTRIGLYCERIDEMIA; METABOLISM; MUTATION; PATHOLOGY; PHYSIOLOGY; PUBERTY;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ADOLESCENT; CAVEOLIN 1; CHILD; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LEPTIN; LIPODYSTROPHY, CONGENITAL GENERALIZED; MUTATION; PUBERTY; YOUNG ADULT;

EID: 79954546193     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000100007     Document Type: Article

References (39)

1. Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl. 1996;413:2-28.
2. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954;14:193-204.
3. Garg A. Acquired and inherited lipodystrophies. New Engl J Med. 2004;350:1220-1234.
4. Seip M. Lipodystrophy and gigantism with associated endocrine manifestation: a new diencephalic syndrome? Acta Pediatr. 1959;48:555-574.
5. Seip M, Trygstad O. Generalized lipodystrophy. Arch Dis Child. 1963;38:447-453.
6. Brunzell JD, Shankle SW, Bethune JE. Congenital generalized lipodystrophy and systemic cystic angiomatosis: the simultaneous occurrence of two unusual syndromes in a single family. Ann Intern Med. 1968;69:501-516.
7. Van Maldergem L, Bacq C, Mommen N, Fourneau C, Hilbert P, Gillerot Y. Total lipodystrophy, polycystic ovaries and cystic angiomatosis of bones (Brunzell syndrome): confirmation of a separate entity. (Abstract) Am J Hum Genet. 1992;51 Suppl A109.
8. Haque W, Garg A, Agarwal A. Enzimatic activity of naturally occurring 1-acylglycerol-3-phosphate-O-acyltransferase 2 mutants associated with congenital generalized lipodystrophy. Biochem Biophys Res Commun. 2005;327:446-453.
9. Kim CA, Delepine M, Boutet E, El Mourabit H, Lay SL, Meier M, et al. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocr Metab. 2008;93:1129-1134.
10. Jaquet D, Khallouf E, Lévy-Marchal C, Czernichow P. Extremely low values of serum leptin in children with congenital generalized lipoatrophy. Eur J Endocrinol. 1999;140:107-109.
11. Beltrand J, Beregszaszi M, Chevenne D, Sebag G, De Kerdanet M, Huet F, et al. Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy. Pediatrics. 2007;120(2):e291-296.
12. Gomes KB, Pardini VC, Fernandes AP. Clinical and molecular aspects of Berardinelli-Seip congenital lipodystrophy. Clin Chim Acta. 2009;402:1-6.
13. Zappalla FR, Gidding SS. Lipid management in children. Endocrinol Metab Clin N Am. 2009;38:171-183.
14. Ibanez L, Potau N, Zampolli M, Prat N, Virdis R, Vicens-Calvet E, et al. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1996;81(3):1237-1243.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
16. Bloomgarden ZT. Measures of insulin sensitivity. Clin Lab Med. 2006;26:611-633.
17. Magré J, Delépine M, Van Maldergem L, Robert J, Maassen JA, Meier M, et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes. 2003;52:1573-1578.
18. Val Maldergem L, Magré J, Khallouf T, Gedde-Dahl T Jr, Delépine M, Trygstad O, et al. Genotype-phenotype relationship in Berardinelli- Seip congenital lipodistrophy. J Med Genet. 2002;39:722-733.
19. Agarwal A, Ariouglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, et al. AGPAT2 is mutated in congenital generalized lipodistrophy linked to chromosome 9q34. Nat Genet. 2002;31:21-23.
20. Salani B, Briatore L, Garibaldi S, Cordera R, Maggi D. Caveolin-1 Down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts. Endocrinology. 2008;149(2):461-465.
21. Payne VA, Grimsey N, Tuthill A, Virtue S, Gray SL, Dalla Nora E, et al. The lipodistrophy gene BSCL2/seipin may be essential for normal adipocyte differentiantion. Diabetes. 2008;57(8):2055-2060.
22. Gomes KB, Fernandes AP, Ferreira AC, Pardini H, Garg A, Magré J, et al. Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate regions of Brazil. J Clin Endocrinol Metab. 2004;89(1):357-361.
23. Fu M, Kazlauskaite R, Baracho MFP, Santos MGN, Brandão-Neto J, Villares S, et al. Mutations in Gng31g and AGPAT2 in Berardinelli- Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. J Clin Endocrinol Metab. 2004;89:2916-2922.
24. Miranda DM, Wajchenberg BL, Calsolari MR, Aguiar MJ, Silva JMCL, Ribeiro MG, et al. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol. 2009;71: 512-517.
25. Figueiredo Filho PP, Val AC, Diamante R, Cunha CF, Norton RC, Lamounier JA, et al. Lipodistrofia generalizada congênita. J Pediatr. 2004;80(4):333-336.
26. Agarwal A, Garg A. Genetic disorders of adipose tissue development, differenciation, and death. Annu Rev Genom Hum Genet. 2006;7:175-199.
27. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes. 2001;50:2444-2450.
28. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
29. Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, et al. Hepatic fat content and insulin action on free fat acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic pacients. Diabetes. 2000:740-758.
30. Storz P, Doppler H, Wernig A, Pfizenmaier K, Muller G.Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells. Eur J Biochem. 1999;266:17-25.
31. Pardini VC, Victória IM, Rocha SM, Andrade DG, Rocha AM, Pieroni FB, et al. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J Clin Endocrinol Metab. 1998;83(2):503-508.
32. Rabe K, Lehrke M, Parhofer KG, Broedl U. Adipokines and insulin resistance. Mol Med. 2008;14(11-12):741-751.
33. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 2005;54:1640-1648.
34. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, et al. Efficacy and safety of statin theraphy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292(3):331-337.
35. de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin theraphy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40(12):2117-2121.
36. Daniels SR, Greer FR; and the Committee on Nutrition. Lipid screening and Cardiovascular Health in Childhood. Pediatrics. 2008;122:198-208.
37. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin replacement theraphy for lipodystrophy. N EnglJ Med. 2002;346:570-578.
38. Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia. 2010; 53:27-35.
39. Beltrand J, Lahlou N, Le Charpentier T, Sebag G, Leka S, Polak M, et al. Resistance to leptin replacement theraphy in Berardinelli-Seip congenital lipodystrophy (BSCL): An immunological origin. Eur J Endocrinol. 2010;162:1083-1091.